Close

Sorin Group acquired endoscopic vessel harvesting business from Datascope, Inc

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today that it has acquired the Clearglide(R) endoscopic vessel harvesting product line of Datascope Inc. Endoscopic vessel harvesting ("EVH") devices enable less-invasive harvesting of vessels for use in coronary artery bypass grafting. EVH procedures replace traditional open vessel harvesting, and avoid significant pain and discomfort for patients. In addition, the large incision that is required in an open vessel harvesting procedure is associated with a high rate of wound complications including dehiscence, hematoma and infection. The endoscopic approach is associated with fewer wound complications than the traditional open method.

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today that it has acquired the Clearglide(R) endoscopic vessel harvesting product line of Datascope Inc. Endoscopic vessel harvesting ("EVH") devices enable less-invasive harvesting of vessels for use in coronary artery bypass grafting. EVH procedures replace traditional open vessel harvesting, and avoid significant pain and discomfort for patients. In addition, the large incision that is required in an open vessel harvesting procedure is associated with a high rate of wound complications including dehiscence, hematoma and infection. The endoscopic approach is associated with fewer wound complications than the traditional open method.

André-Michel Ballester, C.E.O. Sorin Group said, After conclusion in 2008 of our divestiture program, this transaction is a first step towards reinforcing our leading cardiac surgery franchises. This acquisition will be particularly exciting for Sorin Group's United States business as it will reinforce our product offering and consolidate our position as the leading provider of innovative solutions for the cardiac surgery clinical community.

Latest stories